IL104734D0 - Bioactive conjugates of cellulose with amino compounds - Google Patents

Bioactive conjugates of cellulose with amino compounds

Info

Publication number
IL104734D0
IL104734D0 IL10473493A IL10473493A IL104734D0 IL 104734 D0 IL104734 D0 IL 104734D0 IL 10473493 A IL10473493 A IL 10473493A IL 10473493 A IL10473493 A IL 10473493A IL 104734 D0 IL104734 D0 IL 104734D0
Authority
IL
Israel
Prior art keywords
cellulose
amino compounds
bioactive conjugates
bioactive
conjugates
Prior art date
Application number
IL10473493A
Original Assignee
Univ Bar Ilan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bar Ilan filed Critical Univ Bar Ilan
Priority to IL10473493A priority Critical patent/IL104734D0/en
Publication of IL104734D0 publication Critical patent/IL104734D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057Ingredients of undetermined constitution or reaction products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815Carrier is a synthetic polymer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/24Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24802Discontinuous or differential coating, impregnation or bond [e.g., artwork, printing, retouched photograph, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/24Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24802Discontinuous or differential coating, impregnation or bond [e.g., artwork, printing, retouched photograph, etc.]
    • Y10T428/24893Discontinuous or differential coating, impregnation or bond [e.g., artwork, printing, retouched photograph, etc.] including particulate material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/20Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
    • Y10T442/2525Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]
IL10473493A 1993-02-15 1993-02-15 Bioactive conjugates of cellulose with amino compounds IL104734D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL10473493A IL104734D0 (en) 1993-02-15 1993-02-15 Bioactive conjugates of cellulose with amino compounds

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IL10473493A IL104734D0 (en) 1993-02-15 1993-02-15 Bioactive conjugates of cellulose with amino compounds
US08/196,390 US5516673A (en) 1993-02-15 1994-02-10 Bioactive conjugates of cellulose with amino compounds
EP19940300991 EP0611573A3 (en) 1993-02-15 1994-02-11 Bioactive conjugates of cellulose with amino compounds.
CA 2115630 CA2115630A1 (en) 1993-02-15 1994-02-14 Bioactive conjugates of cellulose with amino compounds
JP5436794A JPH07330803A (en) 1993-02-15 1994-02-15 Bioactive conjugate of cellulose with amino compound
US08/416,351 US5855987A (en) 1993-02-15 1995-04-04 Bioactive conjugates of cellulose with amino compounds

Publications (1)

Publication Number Publication Date
IL104734D0 true IL104734D0 (en) 1993-06-10

Family

ID=11064528

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10473493A IL104734D0 (en) 1993-02-15 1993-02-15 Bioactive conjugates of cellulose with amino compounds

Country Status (5)

Country Link
US (2) US5516673A (en)
EP (1) EP0611573A3 (en)
JP (1) JPH07330803A (en)
CA (1) CA2115630A1 (en)
IL (1) IL104734D0 (en)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK100592D0 (en) 1992-08-10 1992-08-10 Mouritsen & Elsner Aps Method for the chemical coupling of solid phases
DE19503338C2 (en) * 1995-02-02 1998-07-30 Lohmann Therapie Syst Lts Dosage form for the delivery of collagenase to wounds and to processes for their preparation and their use
IL118848D0 (en) * 1996-07-14 1996-10-31 Univ Bar Ilan Method for preparing bioactive polymers
IL127209D0 (en) * 1998-11-23 1999-09-22 Bio Silk Ltd Composition and method for treatment of hypertrophic skin accumulations and their prevention
ITMI991458A1 (en) * 1999-07-01 2001-01-02 Ring Holding S P A Biopolymers are not digestible and / or non-absorbable chemically derivatized such as competitive antagonists of nut intestinal absorption
NZ520261A (en) 2000-01-10 2003-10-31 Maxygen Holdings Ltd Granulocyte colony-stimulating factor PEG conjugates that exhibit an increased bioavailability and half-life in vivo and reduced side effects and immunogenicity
AT428445T (en) 2000-02-11 2009-05-15 Bayer Healthcare Llc Cleaning factor vii or viia conjugate
US6749865B2 (en) 2000-02-15 2004-06-15 Genzyme Corporation Modification of biopolymers for improved drug delivery
SK11882003A3 (en) 2001-02-27 2004-03-02 Maxygen Aps New interferon beta-like molecules
WO2002073158A2 (en) * 2001-03-09 2002-09-19 Apollo Biotechnology, Inc. Conjugate probes and optical detection of analytes
ITMI20011238A1 (en) * 2001-06-12 2002-12-12 Bartholdy Consultadoria E Serv Polymers of conjugated polysaccharide natural origin chemically asostanze pharmacologically or biologically active and their properties'
AT371680T (en) 2002-01-16 2007-09-15 Biocompatibles Uk Ltd polymer conjugates
US20030159200A1 (en) * 2002-02-28 2003-08-28 Don Elrod Antimicrobial fabrics through surface modification
BR0311978A (en) 2002-06-21 2005-03-22 Novo Nordisk Healthcare Ag Preparation, method for preparing it, pharmaceutical formulation, methods for treating a factor responsive syndrome vii, to prevent unwanted bleeding, to prevent unwanted blood clotting and to prevent tissue factor mediated reactions, and to use a preparation
US6774206B2 (en) * 2002-09-26 2004-08-10 Bayer Polymers Llc Polyaspartate resins with improved flexibility
GB0301014D0 (en) * 2003-01-16 2003-02-19 Biocompatibles Ltd Conjugation reactions
AT481420T (en) 2003-10-10 2010-10-15 Novo Nordisk As Il-21 derivatives
EP2641611A3 (en) 2003-10-17 2013-12-18 Novo Nordisk A/S Combination therapy
AT413819B (en) * 2003-10-31 2006-06-15 Chemiefaser Lenzing Ag Cellulose derivative
NZ548255A (en) 2004-02-02 2010-10-29 Ambrx Inc Modified human interferon polypeptides and their uses
US7842382B2 (en) * 2004-03-11 2010-11-30 Knauf Insulation Gmbh Binder compositions and associated methods
CA2568952C (en) 2004-06-18 2019-05-21 Ambrx, Inc. Novel antigen-binding polypeptides and their uses
AU2005327906B2 (en) * 2004-07-21 2010-05-13 Ambrx, Inc. Biosynthetic polypeptides utilizing non-naturally encoded amino acids
CA2584271A1 (en) * 2004-10-13 2006-04-27 Knauf Insulation Gmbh Polyester binding compositions
AU2005322019B2 (en) 2004-12-22 2010-08-26 Ambrx, Inc. Formulations of human growth hormone comprising a non-naturally encoded amino acid
MX2007007581A (en) * 2004-12-22 2007-07-24 Ambrx Inc Compositions of aminoacyl-trna synthetase and uses thereof.
BRPI0518661A2 (en) 2004-12-22 2008-12-02 Ambrx Inc Methods for expression and purification of recombinant human growth hormone
AT542920T (en) 2004-12-22 2012-02-15 Ambrx Inc Modified human growth hormone
CA2609205A1 (en) * 2005-06-03 2006-12-14 Ambrx, Inc. Improved human interferon molecules and their uses
EP1893632B1 (en) 2005-06-17 2015-08-12 Novo Nordisk Health Care AG Selective reduction and derivatization of engineered factor vii proteins comprising at least one non-native cysteine
KR101963076B1 (en) * 2005-07-26 2019-03-27 크나우프 인설레이션, 인크. Binders and materials made therewith
AU2005335491B2 (en) * 2005-08-18 2010-11-25 Ambrx, Inc. Compositions of tRNA and uses thereof
WO2007056448A2 (en) * 2005-11-08 2007-05-18 Ambrx, Inc. Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
KR20080079643A (en) * 2005-11-16 2008-09-01 암브룩스, 인코포레이티드 Methods and compositions comprising non-natural amino acids
WO2007070659A2 (en) * 2005-12-14 2007-06-21 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
EP2029738A2 (en) 2006-05-24 2009-03-04 Novo Nordisk Health Care AG Factor ix analogues having prolonged in vivo half life
MX2009002526A (en) * 2006-09-08 2009-04-16 Ambrx Inc Suppressor trna transcription in vertebrate cells.
DK2615108T3 (en) 2006-09-08 2017-01-30 Ambrx Inc Modified human plasma polypeptide or fc scaffolds and their applications
MX2009002460A (en) * 2006-09-08 2009-03-20 Ambrx Inc Hybrid suppressor trna for vertebrate cells.
EP2108026A1 (en) 2007-01-25 2009-10-14 Knauf Insulation Limited Composite wood board
US8082609B2 (en) * 2007-01-25 2011-12-27 Best Bath Systems, Inc. Walk-in bathtub having a flip-up seat portion over a rearward foot well recess
BRPI0721233A2 (en) 2007-01-25 2013-01-01 Knauf Insulation Ltd non-formaldehyde mineral fiber insulating product
WO2008089848A1 (en) * 2007-01-25 2008-07-31 Knauf Insulation Limited Mineral fibre insulation
EP2108006A1 (en) 2007-01-25 2009-10-14 Knauf Insulation GmbH Binders and materials made therewith
CA2682147C (en) 2007-03-30 2017-08-08 Ambrx, Inc. Modified fgf-21 polypeptides and their uses
EP2137223B1 (en) 2007-04-13 2019-02-27 Knauf Insulation GmbH Composite maillard-resole binders
WO2008137471A2 (en) * 2007-05-02 2008-11-13 Ambrx, Inc. Modified interferon beta polypeptides and their uses
CN101802031B (en) * 2007-07-05 2012-10-17 可耐福保温材料有限公司 Hydroxymonocarboxylic acid-based maillard binder
GB0715100D0 (en) * 2007-08-03 2007-09-12 Knauf Insulation Ltd Binders
EP2399610A3 (en) * 2007-09-24 2012-09-05 Bar-Ilan University Polymer nanoparticles coated by magnetic metal oxide and uses thereof
MX338336B (en) * 2007-11-20 2016-04-07 Ambrx Inc Modified insulin polypeptides and their uses.
CN103694337B (en) 2008-02-08 2016-03-02 Ambrx公司 Modified leptin polypeptides and uses thereof
AU2009274076C1 (en) 2008-07-23 2014-04-17 Ambrx, Inc. Modified bovine G-CSF polypeptides and their uses
JP5709754B2 (en) 2008-09-26 2015-04-30 アンブルックス,インコーポレイテッドAmbrx,Inc. Microorganisms and vaccines that rely on replication with unnatural amino acids
BRPI0919403A2 (en) 2008-09-26 2017-09-26 Ambrx Inc modified animal erythropoietin polypeptides and their uses
CZ301899B6 (en) * 2009-03-17 2010-07-21 Contipro C, A.S. Process for preparing derivatives of hyaluronic acid using O-acyl-O?-alkylcarbonate in the presence of substituted pyridine
IT1395129B1 (en) * 2009-07-30 2012-09-05 Franzoni Filati S P A Aminoglycosides and aminoglycosides pregelatinized covalently conjugated to cotton
US8900495B2 (en) 2009-08-07 2014-12-02 Knauf Insulation Molasses binder
CA2784800A1 (en) 2009-12-21 2011-07-21 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
MX349301B (en) 2009-12-21 2017-07-21 Ambrx Inc Modified bovine somatotropin polypeptides and their uses.
AU2011222883B2 (en) 2010-03-05 2016-05-26 Omeros Corporation Chimeric inhibitor molecules of complement activation
AU2011249759B2 (en) 2010-05-07 2014-11-06 Knauf Insulation Carbohydrate polyamine binders and materials made therewith
EA025774B1 (en) 2010-05-07 2017-01-30 Кнауф Инзулацьон Methods of making fibers bound by cured polymeric binder, composition and composite wood board
JP2013528374A (en) 2010-05-10 2013-07-11 パーシード セラピューティクス リミテッド ライアビリティ カンパニー Polypeptide inhibitors of VLA4
BR112013003522A8 (en) 2010-08-17 2017-12-26 Ambrx Inc "modified relaxin polypeptides comprising a non-naturally encoded amino acid, use, method of preparation as well as nucleic acid encoding them"
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
RU2452510C1 (en) * 2011-02-08 2012-06-10 Общество с ограниченной ответственностью "Саентифик Фьючер Менеджмент" ООО "Саентифик Фьючер Менеджмент" Analgesic
BR112014000055A2 (en) 2011-07-01 2017-06-13 Bayer Ip Gmbh relaxin fusion polypeptides and uses thereof
GB201206193D0 (en) 2012-04-05 2012-05-23 Knauf Insulation Ltd Binders and associated products
EP3505534A1 (en) 2012-06-08 2019-07-03 Sutro Biopharma, Inc. Antibodies comprising sitespecific nonnatural amino acid residues, methods of their preparation and methods of their use
EP3135690A1 (en) 2012-06-26 2017-03-01 Sutro Biopharma, Inc. Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
GB201214734D0 (en) 2012-08-17 2012-10-03 Knauf Insulation Ltd Wood board and process for its production
SI2890402T1 (en) 2012-08-31 2019-07-31 Sutro Biopharma, Inc. Modified amino acids comprising an azido group
US9764039B2 (en) 2013-07-10 2017-09-19 Sutro Biopharma, Inc. Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
EP3055298A1 (en) 2013-10-11 2016-08-17 Sutro Biopharma, Inc. Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
CN110078814A (en) 2014-10-24 2019-08-02 百时美施贵宝公司 FGF-21 polypeptide of modification and application thereof
KR20190115049A (en) 2017-02-08 2019-10-10 브리스톨-마이어스 스큅 컴퍼니 Modified relaxin polypeptides comprising pharmacokinetic enhancers and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU117365A1 (en) * 1957-10-03 1957-11-30 А.Е. Лаптев Track machine for cutting frozen soil near railway track sleepers
US4229537A (en) * 1978-02-09 1980-10-21 New York University Preparation of trichloro-s-triazine activated supports for coupling ligands
CS249311B1 (en) * 1983-09-29 1987-03-12 Jaroslava Turkova Proteolytic wound dressing
SE460017B (en) * 1984-03-14 1989-09-04 Landstingens Inkopscentral Bacterial adsorption composition in the form vattenoloeslig
DK108685A (en) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Growth Factor in
US5028531A (en) * 1984-03-19 1991-07-02 Fujisawa Pharmaceutical Company, Ltd. IGF-I fusion proteins; protection of IGF-I from degradation by host cell; and processes for the production thereof
DD279486A1 (en) * 1986-03-10 1990-06-06 Akad Wissenschaften Ddr Process for activating hydroxyl group-containing polymer compounds
DE3723897A1 (en) * 1987-07-18 1989-01-26 Akzo Gmbh Cellulose derivatives and products thereof fibers and membranes
DD291477A5 (en) * 1990-01-09 1991-07-04 Vnii Textilno-Galantereinoi Promyshlennesti "Textilgalantereya",Su Method for producing a biologically active material
US5053423A (en) * 1990-03-22 1991-10-01 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5238940A (en) * 1990-03-22 1993-08-24 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5330823A (en) * 1993-03-19 1994-07-19 Xerox Corporation Transparent recording sheets

Also Published As

Publication number Publication date
EP0611573A2 (en) 1994-08-24
US5516673A (en) 1996-05-14
CA2115630A1 (en) 1994-08-16
JPH07330803A (en) 1995-12-19
EP0611573A3 (en) 1995-11-15
US5855987A (en) 1999-01-05

Similar Documents

Publication Publication Date Title
GB2282071B (en) Applicator
EG24435A (en) Novel pharmaceutical composition
EG20671A (en) New peptides derivatives
PL187408B1 (en) Osteoprotegrin
HK1006937A1 (en) Fiber-resin composition
PL181694B1 (en) Cyanide derivatives
CY2210B1 (en) Pharmaceutical composition
IE911486A1 (en) Pharmaceutical composition
PL177905B1 (en) Napkin
GB9309324D0 (en) Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
ZA9509469B (en) Pharmaceutical composition
PL172824B1 (en) Novel thioether conjugates
GB9317764D0 (en) Therapeutic compound
GB9426252D0 (en) Pharmaceutical composition
PL177899B1 (en) Napkin
GB9404945D0 (en) Pharmaceutical composition
HU9403376D0 (en) Cosmetic composition
ZA9401172B (en) Cosmetic composition
GB9308103D0 (en) Cosmetic composition
HUT71745A (en) Substituted 1-aryl-pyrazol derivatives
GB9322007D0 (en) Cosmetic composition
ZA9405710B (en) Cosmetic composition
HK1053314A1 (en) Therapeutic peptide derivatives
ZA9405711B (en) Cosmetic composition
ZA9405712B (en) Cosmetic composition